期刊文献+

促血小板生成制剂治疗慢性难治性特发性血小板减少性紫癜的发展概况 被引量:5

下载PDF
导出
摘要 特发性血小板减少性紫癜(idiopathic thrombocytopenic purpura.ITP),是一种自身抗体介导的血小板过度破坏引起的出血性疾病,因此,抑制血小板破坏成为治疗的主要手段。同样.对慢性难治性ITP的传统治疗方法,是用免疫抑制剂(如激素、环孢素)、免疫调节剂(球蛋白制剂、单克隆自身抗体)和去除破坏部位(切脾、脾放疗)等针对血小板破坏进行治疗的。近些年,
作者 王志清
出处 《实用医学杂志》 CAS 北大核心 2010年第3期513-514,共2页 The Journal of Practical Medicine
  • 相关文献

参考文献19

  • 1Ballem P J, Segal G M, Stratton J R, et al. Mechanisms of thrombocytopenia in chronic autoimmune thrombocytopenia purpura. Evidence for both impaired platelet production and increased platelet clearance [ J ]. J Clin Invest, 1987,80 ( 1 ) : 33-40.
  • 2McDonald T P. Thrombopoietin: Its biology, clinical aspects, and possibilities [J]. Am J Pediatr Hematol Oncol, 1992, 14 (1) :8-21.
  • 3Begley C G, Basser R L. Biologic and structural differences of thrombopoietic growth factors [J]. Semin Hematol,2000, 37(Suppl 4) : 19-27.
  • 4Kuter D J, Goodnough L T, Romo J, et al. Thrombopoietin therapy increases platelet yields in healthy platelet donors [J]. Blood, 2001,98(5) : 1339-1345.
  • 5Nomura S, Dan K, Hotta T, et al. Effects of pegylated recombinant human megakaryocyte growth and development factor in patients with idiopathic thrombocytopenic purpura [J].Blood, 2002,100(2) :728-730.
  • 6Rice L, Nichol J L, McMillan R,et al. Cyclic immune thrombocytopenia responsive to thrombopoietic growth factor therapy [ J ]. Am J Hematol, 2001,68 (3) : 210-214.
  • 7Kuter D J, Begley C G. Recombinant human thrombopoietin: basic biology and evaluation of clinical studies [J]. Blood, 2002,100(10) : 3457-3469.
  • 8赵永强,姜杰玲,焦力,潘家琦,陈书长,王书杰,单渊东,沈悌,武永吉.重组人血小板生成素临床耐受性试验[J].中华医学杂志,2001,81(24):1508-1511. 被引量:35
  • 9赵永强,王庆余,翟明,徐健,陈协群,刘文励,张梅,宋善俊,王健民,孟凡义,单渊东.重组人血小板生成素治疗慢性难治性特发性血小板减少性紫癜的多中心临床试验[J].中华内科杂志,2004,43(8):608-610. 被引量:102
  • 10Kuter D J. New thrombopoietic growth factors [ J ]. Blood, 2007,109 ( 11 ) : 4607- 4616.

二级参考文献10

共引文献139

同被引文献38

  • 1贺艳娟,李晓林,祝焱,赵谢兰,舒毅刚.重组人白介素-11治疗复发重症特发性血小板减少性紫癜的临床观察[J].中国现代医学杂志,2008,18(21):3187-3189. 被引量:2
  • 2张华,陶晓明,邓燕艺,李虎生.重组人白介素-11联合肾上腺皮质激素治疗特发性血小板减少性紫癜的临床观察[J].临床血液学杂志,2005,18(3):138-139. 被引量:13
  • 3沈伟,徐旻,姚乃中.补肾方治疗难治性血小板减少性紫癜40例的疗效观察[J].黑龙江中医药,2007,36(4):5-6. 被引量:8
  • 4Cines DB, Blanchette VS. Immune thrombocytopenic purpura [ J ]. N Engl J Med ,2002,346:995 - !,008.
  • 5Chang M,Nakagawa PA, Williams SA, et al. Immune thrombocyto- penie purpura(ITP) plasma and purified ITP monnelonal autoantl- bodies inhibit megakary0 cytopoiesis in vitro[ J]. Blood,2003,102 : 887 - 895.
  • 6Houwerzijl E J, Blom NR, van der Want JJ, et al. Ultrastructural study shows morphologic features of apoptosis and para-apoptosis in megakaryocytes from patients with idiopathic thrombocytopenic pur- pura[ J ]. Blood,2004,103:500 - 506.
  • 7Cohen YC, Djulbegovic B, Shamai-Lubovitz O, et al. The bleeding risk and natural history of idiopathic thrombocytopenic purpura in patients with persistent low platelet counts[J]. Arch Intern Med, 2000,160 : 1630 - 1625.
  • 8Hao J,Sun L, Huan H,et al. Effectsofrecombinant human interleu- kin- 11 on thrombocytopenia and neutropenia in irradiated rhesus monkeys[J]. Radiat Res,2004,162(2) :157 -163.
  • 9Tsimberidou AM, Giles FJ, Khouri I, et al. Low-dose inter-leukin - 11 in patients with bone marrow failure:update of the M. D. Ander- son Cancer Center experience [ J ]. Ann Oncol,2005,16 ( 1 ) : 139 - 145.
  • 10Bartley TD, Bogenberger J, Hunt P, et al. Identification and cloning of a megakaryocyte growth and development factor that is a ligand for the cytokine receptor Mpl [ J ]. Cell, 1994, 77(7) :1117-1124.

引证文献5

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部